Hedge funds' growing divide
One manager, Steve Cohen's Point72, has a waitlist of $9 billion to get into its funds.
ResMed added to APAC Conviction List at Goldman Sachs
Goldman Sachs analysts added ResMed (RMD) to the firm’s APAC Conviction List as part of its monthly update. The firm expects “robust” ...